You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ALL in first remission, in a high-risk category

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphoblastic Leukemia, Adult Trial in Caba (Evaluation of survival and toxicities in AYA Ph-negative ALL patients

Recruiting
  • Acute Lymphoblastic Leukemia, Adult
  • Evaluation of survival and toxicities in AYA Ph-negative ALL patients treating in first line depending on risk category.
  • Paraná, Entre Ríos, Argentina
  • +1 more
Dec 29, 2022

Diffuse Large B-cell Lymphoma Trial in Changchun (Mitoxantrone HCl liposome injection, RiTUXimab Injection, Cyclophosphamid)

Not yet recruiting
  • Diffuse Large B-cell Lymphoma
  • Mitoxantrone hydrochloride liposome injection
  • +4 more
  • Changchun, Jilin, China
    The First Bethune Hospital of Jilin University
Aug 15, 2023

Neuroblastoma Trial in New York (Hu3F8, GM-CSF, Isotretinoin)

Active, not recruiting
  • Neuroblastoma
  • Hu3F8
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 1, 2022

ACUTE LYMPHOBLASTIC LEUKEMIA Trial (Inotuzumab ozogamicin, ALLR3)

Not yet recruiting
  • ACUTE LYMPHOBLASTIC LEUKEMIA
  • (no location specified)
Feb 17, 2023

Neuroblastoma Trial in Worldwide (Naxitamab, GM-CSF, Isotretinoin)

Recruiting
  • Neuroblastoma
  • Kowloon, Hong Kong
  • +8 more
Jan 31, 2022

B-cell Acute Lymphoblastic Leukemia Trial in Suzhou (Blinatumomab, Conventional therapy)

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • Suzhou, Jiangsu, China
    The first affiliated hospital of Soochow University
Sep 26, 2022

Neuroblastoma Trial in United States (DFMO)

Active, not recruiting
Has Results
  • Neuroblastoma
  • Phoenix, Arizona
  • +21 more
Jan 25, 2023

AML, MDS, Old Age; Debility Trial in Suzhou (Azacitidine, all trans retinoic acid)

Recruiting
  • AML
  • +3 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Dec 27, 2021

Acute Lymphocytic Leukaemia; Acute Myeloid Leukaemia Refractory; Myelodysplastic Syndrome Trial in Australia, Netherlands,

Recruiting
  • Acute Lymphocytic Leukaemia; Acute Myeloid Leukaemia Refractory; Myelodysplastic Syndrome
  • Duarte, California
  • +12 more
Jan 4, 2023

Acute Promyelocytic Leukemia Trial in Xi'an (Realgar-Indigo naturalis formula, all-trans retinoic acid, Arsenic trioxide)

Recruiting
  • Acute Promyelocytic Leukemia
  • Realgar-Indigo naturalis formula
  • +3 more
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xi'an Jiaotong University
Aug 31, 2021

Leukemia, Myeloid, Acute Trial in Germany (Human Stem Cell Transplantation, Consolidation chemo, i.e. High-dose Cytarabine

Terminated
  • Leukemia, Myeloid, Acute
  • Human Stem Cell Transplantation
  • Consolidation chemotherapy, i.e. High-dose Cytarabine (HiDAC)
  • Aachen, Germany
  • +18 more
Oct 28, 2021

Multiple Myeloma Trial in Little Rock (myPRS, Induction 1 - MEL-10+CFZ-TD-PACE, First Transplant - MEL-80+CFZ-TD-PACE + PBSC

Terminated
Has Results
  • Multiple Myeloma
  • myPRS
  • +6 more
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
May 28, 2021

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult

Terminated
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +9 more
  • Allogeneic Bone Marrow Transplantation
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 4, 2021

Hodgkin Lymphoma in First Complete Remission

Completed
  • Hodgkin Lymphoma
  • +2 more
  • Standard cohort: Clinical lab follow-up
  • Imaging cohort: integrated imaging follow-up
  • (no location specified)
Mar 4, 2020

Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma Trial in Australia, United States (Prednisone, Vincristine,

Recruiting
  • Acute Lymphoblastic Leukemia
  • Acute Lymphoblastic Lymphoma
  • Palo Alto, California
  • +6 more
May 2, 2022

Acute Myeloid Leukemia Trial in Worldwide (Pracinostat, Placebos, Azacitidine)

Terminated
Has Results
  • Acute Myeloid Leukemia
  • Phoenix, Arizona
  • +137 more
Mar 9, 2022

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Completed
Has Results
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +23 more
  • Denver, Colorado
  • +2 more
Jun 17, 2021

MDD, Treatment Resistant Depression Trial in Worldwide (Esketamine Nasal Product, Ketamine Hydrochloride, Esketamine HCl)

Not yet recruiting
  • Major Depressive Disorder
  • Treatment Resistant Depression
  • Esketamine Nasal Product
  • +3 more
  • Innsbruck, Austria
  • +12 more
Jul 25, 2023

Bipolar Depression Trial in Worldwide (Escitalopram, Sertraline, Duloxetine)

Not yet recruiting
  • Bipolar Depression
  • Innsbruck, Austria
  • +12 more
Jul 25, 2023

Diabetic Foot Trial in Madrid (2 weeks revision)

Not yet recruiting
  • Diabetic Foot
  • 2 weeks revision
  • Madrid, Spain
    Clínica Universitaria de Podología de la Universidad Complutense
Nov 15, 2023

Multiple Myeloma, Cancer, Hematologic Cancer Trial in Cork (Discontinuation of maintenance treatment)

Not yet recruiting
  • Multiple Myeloma
  • +2 more
  • Discontinuation of maintenance treatment
  • Cork, Ireland
    Cork University Hospital
May 10, 2023

B Acute Lymphoblastic Leukemia, Ph-Negative ALL, High Risk Acute Lymphoblastic Leukemia Trial (Azacitidine Injection,

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • +2 more
  • Azacitidine Injection
  • +2 more
  • (no location specified)
Oct 15, 2023

Metastatic and/or Advanced Renal Cell Carcinoma, Treated With

Completed
Has Results
  • Carcinoma
  • Renal Cell
  • London, United Kingdom
    Pfizer UK
Jan 9, 2023

RWE of 1st Line Treatment With ATO/ATRA for Adult APL

Recruiting
  • Promyelocytic Leukemia, Adult Acute
  • Evaluation of first line treatment with ATO/ATRA outcome
  • Caba, Argentina
  • +1 more
Nov 9, 2021

Chronic Lymphocytic Leukemia Trial in Cologne (Ibrutinib, Placebo)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Cologne, Germany
    German CLL Study Group
Dec 16, 2021